- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Digital mammography analysts wait for results
Studies have failed to provide a slam-dunk for digital mammography over traditional film x-rays, according to a recent technology assessment report from the ECRI group.
Studies have failed to provide a slam-dunk for digital mammography over traditional film x-rays, according to a recent technology assessment report from the ECRI group.
ECRI, a nonprofit health services research agency, found that digital mammography's ability to detect breast cancer provides no significant improvement over film mammography.
The report reviewed three previously published screening trials that compared the two technologies: a study by Lewin et al published in the September 2002 issue of the American Journal of Roentgenology and the Oslo I and Oslo II screening trials.
While current research indicates that digital mammography may reduce recall rates as well as follow-up procedures, more evidence is needed to confirm these benefits, the ECRI report said.
Mammographers should wait for the results of the ACRIN trial before jumping into a digital purchase, said Dr. Etta Pisano, chief of breast imaging at the University of North Carolina and principal investigator for the American College of Radiology Imaging Network protocol 6652 trial.
The Digital Mammographic Imaging Screening Trial is the most recent study to compare digital and screen-film mammography. It was not included in the ECRI report. Results will be presented in September at the ACRIN meeting in Washington, DC.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
